Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NeuBase Therapeutics
(NBSE) Q1 2023
Earnings
NBSE
May 11
Confirmed
Aug 2022
Dec 2022
Q4 2022
Q1 2023
-0.3
-0.24
-0.17
-0.11
Details
Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
-9.09%
Description
NeuBase Therapeutics (NBSE) has reported earnings of -0.12 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login